Virtual CE Event - All OD's are Welcome
A new collaborative effort between states to help further our shared goal of providing first-class, relevant and timely optometric continuing education.
Please join your colleagues from Maine, New Hampshire, and Rhode Island as we learn about an emerging class of chemotherapeutic agents that put optometrists on the front lines of comprehensive medical eye care.
(ALL Licensed Optometrist Welcome for this timely and important topic)
Wednesday May 22, 2024 7:00 p.m. Remote Meeting (Zoom Platform)
7:00 p.m. - Welcome & Introductions
Lecturer - Dr. Kristen Lamoreau
Update in Chemotherapy and Ocular Adverse Events
Update in Chemotherapy and Ocular Adverse Events – COPE Pending
This course will review recent literature and clinical cases that were co-managed with Beth Israel Deaconess Oncology service at BIDMC Longwood Medical Eye Clinic and includes a review of specific protocols for increasingly common drugs, such as TIVDAK or Elahere. Both drugs are known to have adverse ocular impacts; the class of immune checkpoint inhibitors and their overall effects on the eye will be discussed. (COPE Accreditation Pending, 1 hour)
Note:
Registrants will receive a ZOOM registration email 3-5 days prior to the date of the Flash CE event. Upon receipt of that email, click the link to register with ZOOM. After doing so, you will receive an automated email with your unique link to this program.
Your unique link will be used to sign onto the webinar and will be used towards the verification of attendance for us to submit to ARBO.
Contact Caroline Fontaine